London, England (PRWEB UK) 8 July 2015
Following on from a successful series of established respiratory events, SMi's conference on COPD will return to Central London this autumn for its 7th annual instalment on 19th & 20th October.
Sponsored by leading CRO, Quintiles, this year’s show will feature an exclusive post conference interactive Quintiles workshop hosted by Senior Director Dr. Graham Clarke, who is the Head of Respiratory & Inflammation at the Early Clinical Development unit; and Dr. Juan Gispert, who currently serves as Senior Medical Director leading the medical Allergy and Respiratory teams.
Set to take place on 21st October at the Holiday Inn Regents Park, the interactive workshop will include 3 key session that will offer a global view on the design, setup and management of clinical trials in COPD patients, based on the wide experience and lessons learned of Quintiles team members.
With a focus on a smarter clinical approach in early COPD clinical development, session one will explore adaptive designs and POC studies, the incorporation of challenge models, functional markers of COPD in adaptive designs and sputum methodologies to enhance key Biomarkers.
Following on from a networking coffee break, session two will provide regulatory and strategic guidance using case studies from compounds currently under development.
The final session will see Quintiles discuss how to maximise efficiency of COPD trials through effective recruitment strategies, patient centric studies and compliance in long term studies.
For further details regarding the conference and interactive workshop, visit the website at http://www.copd-conference.co.uk
CLICK HERE to download a brochure for COPD 2015
19th & 20th October 2015
Holiday Inn Regents Park Hotel, London UK
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Quintiles transnational (NYSE: Q), is a Fortune 500 companyand the world’s largest provider of biopharmaceutical development and commercial outsourcing services with network of more than 32,000 employees conducting business in approximately 100 countries. http://www.http://www.quintiles